BioSyent Inc.: BioSyent Inc. Announces Q3 Results: Sales Up 153% for the Qtr, 90% for 9 Months; Ytd Net Income $ 296,491
15th Nov 2006, 00:33 GMT
MISSISSAUGA, ONTARIO (MARKET WIRE)
BioSyent Inc.: BioSyent Inc. Announces Q3 Results: Sales Up 153% for the Qtr, 90% for 9 Months; Ytd Net Income $ 296,491 related news:
- Human Pheromone Sciences Announces Q3 Results — StratWire - Business of Healthcare NewsFeed
- Viscount Systems Inc.: Viscount Reports Q3 2006 Results — Market Wire - Telecom
- EXX INC Announces Third Quarter Consolidated Sales and Net Income for 2006 — Automotive Headlines
- Perceptron, Inc.: Perceptron Announces First Quarter Results for Fiscal Year 2007 and Receipt of First Order for Commercial Products — Market Wire - Automotive
- Max Re Posts $26.5 Million Q3 Net Income; Names Becker Chairman, CEO — Insurance Journal
- Wilmington Capital Management Inc.: Wilmington Announces 2006 Third Quarter Results — Market Wire - Agriculture
- Orion HealthCorp Announces Q3 Results — StratWire - Business of Healthcare NewsFeed
- DAC Technologies Group International, Inc.: DAC Technologies Announces Quarterly Results for Period Ending September 30, 2006 — Market Wire - Manufacturing and Production
- Perceptron Announces Q1 Results for FYE 2007 and Receipt of 1st Order for Commercial Products — StratWire - Business of Healthcare NewsFeed
- MQ Assoc Announces Results for Q3 of 2006 and 9 Months Ended 9/30/2006 — Executive Announcements News from StratCenter.com
Latest news from Market Wire - Medical and Healthcare:
- slp3D: ORLive Presents: Minimally Invasive Aortic Valve Replacement Surgery -- Increasingly Popular Procedure to Correct Heart Function
- Precise Biometrics AB: Extraordinary general meeting of Precise Biometrics AB approves of new share issue with preferential rights for shareholders of approximately SEK 85 million
- Lenstec, Inc.: Lenstec Receives FDA Clearance to Begin Clinical Trial of Softec HD IOL
- Takeda Pharmaceuticals North America: New Data Show ACTOS(R) (pioglitazone HCl) Halted Progression of Atherosclerosis as Indicated by CIMT in Patients With Type 2 Diabetes
- Dairy Fresh Farms Inc.: Dairy Fresh Farms Announces It Has Signed a Licensing Deal With NutriOne for the Canadian Market
- OTSP: Study to Be Published in JAMA: Diabetes Drug ACTOS(R) (pioglitazone HCl) Halted Progression of Key Marker for Atherosclerosis; Improvements Indicated by Carotid Intima-Media Thickness (CIMT)
- Vue Technology: Vue Technology Introduces First UHF Solution for Item-Level Visibility in the Retail Pharmacy; New RFID Solution Tracks Liquids, Pill Bottles, Blister Packs and Gels
- Union Dental Holdings, Inc.: Union Dental Signs Contract to Provide Dental Network for United Association of Plumbers and Pipefitters
- MEDSEEK: MEDSEEK, SelfCareNet, & Primetime Medical Partner to Deliver Integrated Consumer-Centric Solution
- Ridgecrest Healthcare Group, Inc.: Ridgecrest Healthcare Group to Acquire NOBO List